Mutation of the Stargardt Disease Gene ( <i>ABCR</i> ) in Age-Related Macular Degeneration

Rando Allikmets(Massachusetts Eye and Ear Infirmary), Noah F. Shroyer(Massachusetts Eye and Ear Infirmary), Nanda Singh(Massachusetts Eye and Ear Infirmary), Johanna M. Seddon(Massachusetts Eye and Ear Infirmary), Richard A. Lewis(Massachusetts Eye and Ear Infirmary), Paul S. Bernstein(Massachusetts Eye and Ear Infirmary), Andy Peiffer(Massachusetts Eye and Ear Infirmary), Norman A. Zabriskie(Massachusetts Eye and Ear Infirmary), Yixin Li(Massachusetts Eye and Ear Infirmary), Amy Hutchinson(Massachusetts Eye and Ear Infirmary), Michael Dean(Massachusetts Eye and Ear Infirmary), James R. Lupski(Massachusetts Eye and Ear Infirmary), Mark Leppert(Massachusetts Eye and Ear Infirmary)
Science
September 19, 1997
Cited by 877

Abstract

Age-related macular degeneration (AMD) is the leading cause of severe central visual impairment among the elderly and is associated both with environmental factors such as smoking and with genetic factors. Here, 167 unrelated AMD patients were screened for alterations in ABCR, a gene that encodes a retinal rod photoreceptor protein and is defective in Stargardt disease, a common hereditary form of macular dystrophy. Thirteen different AMD-associated alterations, both deletions and amino acid substitutions, were found in one allele of ABCR in 26 patients (16%). Identification of ABCR alterations will permit presymptomatic testing of high-risk individuals and may lead to earlier diagnosis of AMD and to new strategies for prevention and therapy.


Related Papers